The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. LMO2 induces T-cell leukemia with epigenetic deregulation of CD4. Cleveland SM, Goodings C, Tripathi RM, Elliott N, Thompson MA, Guo Y, Shyr Y, Davé UP (2014) Exp Hematol 42(7): 581-93.e5
    › Primary publication · 24792354 (PubMed) · PMC4241760 (PubMed Central)
  2. LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways. Smith S, Tripathi R, Goodings C, Cleveland S, Mathias E, Hardaway JA, Elliott N, Yi Y, Chen X, Downing J, Mullighan C, Swing DA, Tessarollo L, Li L, Love P, Jenkins NA, Copeland NG, Thompson MA, Du Y, Davé UP (2014) PLoS One 9(1): e85883
    › Primary publication · 24465765 (PubMed) · PMC3897537 (PubMed Central)
  3. Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approach. Seegmiller AC, Kim AS, Mosse CA, Levy MA, Thompson MA, Kressin MK, Jagasia MH, Strickland SA, Reddy NM, Marx ER, Sinkfield KJ, Pollard HN, Plummer WD, Dupont WD, Shultz EK, Dittus RS, Stead WW, Santoro SA, Zutter MM (2013) Am J Clin Pathol 140(5): 643-50
    › Primary publication · 24124142 (PubMed) · PMC4159763 (PubMed Central)
  4. HDAC3 is essential for DNA replication in hematopoietic progenitor cells. Summers AR, Fischer MA, Stengel KR, Zhao Y, Kaiser JF, Wells CE, Hunt A, Bhaskara S, Luzwick JW, Sampathi S, Chen X, Thompson MA, Cortez D, Hiebert SW (2013) J Clin Invest 123(7): 3112-23
    › Primary publication · 23921131 (PubMed) · PMC3696547 (PubMed Central)
  5. Targeting nonclassical oncogenes for therapy in T-ALL. Subramaniam PS, Whye DW, Efimenko E, Chen J, Tosello V, De Keersmaecker K, Kashishian A, Thompson MA, Castillo M, Cordon-Cardo C, Davé UP, Ferrando A, Lannutti BJ, Diacovo TG (2012) Cancer Cell 21(4): 459-72
    › Primary publication · 22516257 (PubMed)
  6. Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1. Boelte KC, Gordy LE, Joyce S, Thompson MA, Yang L, Lin PC (2011) PLoS One 6(4): e18534
    › Primary publication · 21494556 (PubMed) · PMC3073977 (PubMed Central)
  7. Co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: possible relationship of two histiocytic disorders in rare cases. O'Malley DP, Duong A, Barry TS, Chen S, Hibbard MK, Ferry JA, Hasserjian RP, Thompson MA, Richardson MS, Jaffe R, Sidhu JS, Banks PM (2010) Mod Pathol 23(12): 1616-23
    › Primary publication · 20729813 (PubMed)
  8. Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy. Davé UP, Akagi K, Tripathi R, Cleveland SM, Thompson MA, Yi M, Stephens R, Downing JR, Jenkins NA, Copeland NG (2009) PLoS Genet 5(5): e1000491
    › Primary publication · 19461887 (PubMed) · PMC2679194 (PubMed Central)
  9. Deletion of Mtg16, a target of t(16;21), alters hematopoietic progenitor cell proliferation and lineage allocation. Chyla BJ, Moreno-Miralles I, Steapleton MA, Thompson MA, Bhaskara S, Engel M, Hiebert SW (2008) Mol Cell Biol 28(20): 6234-47
    › Primary publication · 18710942 (PubMed) · PMC2577421 (PubMed Central)
  10. Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion oncoprotein. Yang G, Thompson MA, Brandt SJ, Hiebert SW (2007) Oncogene 26(1): 91-101
    › Primary publication · 16799637 (PubMed)
  11. Non-Hodgkin's lymphoma involving the liver: clinical and therapeutic considerations. Salmon JS, Thompson MA, Arildsen RC, Greer JP (2006) Clin Lymphoma Myeloma 6(4): 273-80
    › Primary publication · 16507204 (PubMed)
  12. Mtgr1 is a transcriptional corepressor that is required for maintenance of the secretory cell lineage in the small intestine. Amann JM, Chyla BJ, Ellis TC, Martinez A, Moore AC, Franklin JL, McGhee L, Meyers S, Ohm JE, Luce KS, Ouelette AJ, Washington MK, Thompson MA, King D, Gautam S, Coffey RJ, Whitehead RH, Hiebert SW (2005) Mol Cell Biol 25(21): 9576-85
    › Primary publication · 16227606 (PubMed) · PMC1265807 (PubMed Central)
  13. The inv(16) cooperates with ARF haploinsufficiency to induce acute myeloid leukemia. Moreno-Miralles I, Pan L, Keates-Baleeiro J, Durst-Goodwin K, Yang C, Kim HG, Thompson MA, Klug CA, Cleveland JL, Hiebert SW (2005) J Biol Chem 280(48): 40097-103
    › Primary publication · 16199529 (PubMed)
  14. Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas. Thompson MA, Stumph J, Henrickson SE, Rosenwald A, Wang Q, Olson S, Brandt SJ, Roberts J, Zhang X, Shyr Y, Kinney MC (2005) Hum Pathol 36(5): 494-504
    › Primary publication · 15948116 (PubMed)